About 1Drop Diagnostics
1Drop Diagnostics is a company based in Neuchatel (Switzerland) founded in 2012. 1Drop Diagnostics has raised $7.75 million across 6 funding rounds from investors including Christian Wildmoser, Hans-Peter Strebel and Beat Schillig. 1Drop Diagnostics offers products and services including Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader. 1Drop Diagnostics operates in a competitive market with competitors including SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
- Headquarter Neuchatel, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 1Drop Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.75 M (USD)
in 6 rounds
-
Latest Funding Round
$4.25 M (USD), Series A
Oct 31, 2018
-
Investors
Venturelab
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 1Drop Diagnostics
1Drop Diagnostics offers a comprehensive portfolio of products and services, including Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader.
Assesses risk of heart disease via high-sensitivity CRP biomarker.
Evaluates cardiovascular risk beyond traditional cholesterol measures.
Checks blood sugar control and diabetes development risk.
Detects underdiagnosed kidney disease through function analysis.
Analyzes blood samples for multiple biomarkers in minutes.
People of 1Drop Diagnostics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of 1Drop Diagnostics
1Drop Diagnostics has successfully raised a total of $7.75M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $4.25 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 1Drop Diagnostics
1Drop Diagnostics has secured backing from 9 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Christian Wildmoser, Hans-Peter Strebel and Beat Schillig.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startup acceleration programs are operated across sectors to support growth.
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
Blackbox is focused on elevating entrepreneurs through global connections.
|
Locked | Locked | Locked |
Investor details for 1Drop Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 1Drop Diagnostics
Investment portfolio details for 1Drop Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 1Drop Diagnostics
Detailed financials for 1Drop Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
1Drop Diagnostics Comparisons
Peer comparison for 1Drop Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 1Drop Diagnostics
1Drop Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
3D holographic display solutions for medical imaging are provided.
|
|
| Locked | Locked | Locked |
Interventional cardiology devices are developed and marketed globally.
|
|
| Locked | Locked | Locked |
Molecular diagnostic tests for cardiovascular disorders are developed and marketed.
|
Detailed competitors of 1Drop Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 1Drop Diagnostics
Complete news archive for 1Drop Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 1Drop Diagnostics
1Drop Diagnostics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
1Drop Diagnostics is headquartered in Neuchatel, Switzerland.
1Drop Diagnostics is a funded company, having raised a total of $7.75M across 6 funding rounds to date.
1Drop Diagnostics was founded in 2012 in Neuchatel, Switzerland, within the health technology sector. Point-of-care diagnostic solutions are offered through finger-prick blood sampling. Lab-on-chip microfluidic technology is utilized to process small blood volumes, while advanced photonics detects fluorescence from immunoassays. Initial focus is placed on cardiovascular health, with biomarkers including NT-proBNP, D-Dimer, Troponin, and C-reactive protein. Operations emphasize accessible testing in clinical settings.
1Drop Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
1Drop Diagnostics offers Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader.
1Drop Diagnostics has 9 investors. Key investors include Christian Wildmoser, Hans-Peter Strebel, Beat Schillig, Jean-Philippe De Toledo, and Venturelab.